Karyopharm Therapeutics reported $17.89M in Trade Debtors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acceleron Pharma XLRN:US $ 27.94M 2.73M
Amgen AMGN:US $ 4479M 56M
AstraZeneca AZN:LN 6.84B 214M
Astrazeneca AZN:US 6.84B 214M
Avrobio Inc AVRO:US 2.33M 407K
Biocryst Pharmaceuticals BCRX:US $ 27.62M 9.23M
Bristol Myers Squibb BMY:US $ 11275M 2615M
Eli Lilly And LLY:US $ 6902.8M 244.2M
Enanta Pharmaceuticals ENTA:US $ 21.62M 1.49M
Epizyme EPZM:US $ 7.12M 2.64M
GlaxoSmithKline GSK:LN 7.51B 324M
Karyopharm Therapeutics KPTI:US $ 17.89M 44K
Macrogenics MGNX:US $ 45.25M 38.1M
Mirati Therapeutics MRTX:US $ 67.12M 65.28M
Nektar Therapeutics NKTR:US $ 28.87M 0.28M
Novartis NVS:US $ 8654M 173M
Novartis NOVN:VX 8.65B 173M
Regeneron Pharmaceuticals REGN:US $ 6998.6M 2825.6M
Sangamo Biosciences SGMO:US $ 7.69M 0.03M
Takeda 4502:JP Y 858957M 46243M
Ultragenyx Pharmaceutical RARE:US $ 24.72M 0.31M
Xencor XNCR:US $ 15.32M 9.7M
YTE INCY:US $ 438.17M 40.81M